Human F7/Coagulation factor VII human

Specification

• Cat#: THP-0059
• Product Name: Human F7/Coagulation factor VII human
• Cas No: Not Available
• Description: The product is human serine protease type enzyme that is involved in the extrinsic coagulation cascade which results in blood clotting.
• Sequences: Not Available
• Species: Human
• Molecular Weight: Not Available
• Formula: Not Available
• Endotoxin: <0.001 EU per 1 μg of the protein by the LAL method
• Application: May be administered in cases of uncontrolled bleeding. Factor VII alone can be used in the treatment of congenital hemophilia A or B, acquired hemophilia, congenital factor VII deficiency, and Glanzmann's thrombasthenia. Off label use in the treatment of refractory bleeding after cardiac surgery and warfarin related intracerebral hemorrhage. Brands for human factor VII are currently only in combination with other vitamin K coagulation factors and can be used to reverse vitamin K antagonist activity in patients with acute major bleeds or for urgent surgery/invasive procedures.

Pharmaceutical Information

• Pharmaceutical Application: Coagulation factor VII human
• Targets: Target 1. Tissue factor; Target 2. Coagulation factor X; Target 3. Coagulation factor IX